Início › Câncer de Próstata › Wisconsin

Ensaios clínicos de Câncer de Próstata em Wisconsin

47 estudos para Câncer de Próstata estão buscando participantes em locais em Wisconsin.

Cidades em Wisconsin

Texto oficial do estudo (Inglês)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Wisconsin Carbone Cancer Center, Madison

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
e mais 25

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 2 de out. de 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Froedtert Menomonee Falls Hospital, Menomonee Falls
Medical College of Wisconsin, Milwaukee
Froedtert and MCW Moorland Reserve Health Center, New Berlin
e mais 2

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 2 de out. de 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
e mais 50

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Marshfield Medical Center-Marshfield, Marshfield
Froedtert Menomonee Falls Hospital, Menomonee Falls
Medical College of Wisconsin, Milwaukee
e mais 2

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06632977

PET/CT Characterization of Treatment Resistance

University of Wisconsin, Madison

Recrutando

Idades 18 e acima · Homens · Atualizado em 1 de out. de 2026 · NCT05647564

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Duluth Clinic Ashland, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
Marshfield Medical Center-EC Cancer Center, Eau Claire
e mais 25

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Medical College of Wisconsin ( Site 0020), Milwaukee

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Medical College Of Wisconsin, Milwaukee

RecrutandoFase 2/3

Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06780670

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Medical College of Wisconsin, Milwaukee

RecrutandoFase 3

Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06855277

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

University Hospital and UW Health Clinics ( Site 0065), Madison
Medical College of Wisconsin ( Site 0008), Milwaukee

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT06925737

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Carbone Cancer Center University of Wisconsin-Madison, Madison

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 15 de set. de 2026 · NCT06150417

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

University of Wisconsin, Madison

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 11 de set. de 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Langlade Hospital and Cancer Center, Antigo
Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
e mais 36

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

Froedtert & the Medical College of Wisconsin, Milwaukee

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 9 de set. de 2026 · NCT07226713

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

UW Health Carbone Cancer Center, Madison

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 3 de set. de 2026 · NCT07005154

The Vanguard Study: Testing a New Way to Screen for Cancer

Zablocki Veterans Administration Medical Center, Milwaukee

RecrutandoVoluntários saudáveis bem-vindos

Idades de 45 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06995898

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT06582017

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

University of Wisconsin Carbone Cancer Center, Madison

RecrutandoEstudo observacional

Idades 18 e acima · Homens · Atualizado em 27 de ago. de 2026 · NCT07050433

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

University of Wisconsin Carbone Cancer Center-Madison, Madison

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 21 de ago. de 2026 · NCT06844383

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Froedtert Hospital, Milwaukee

Recrutando

Idades 65 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07227077

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
Marshfield Medical Center-EC Cancer Center, Eau Claire
University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
e mais 13

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Wisconsin, Carbone Cancer Center, Madison

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

University of Wisconsin Carbone Cancer Center, Madison
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee

RecrutandoFase 1

Idades de 18 a 100 · Homens · Atualizado em 13 de ago. de 2026 · NCT05519449

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

University of Wisconsin-Madison, Madison

RecrutandoEstudo observacional

Idades 18 e acima · Homens · Atualizado em 12 de ago. de 2026 · NCT04489719

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Medical College of Wisconsin, Milwaukee

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 31 de jul. de 2026 · NCT06613100

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Mayo Clinic Health System-Eau Claire, Eau Claire
Mayo Clinic Health System-Franciscan Healthcare, La Crosse

Recrutando

Idades 18 e acima · Homens · Atualizado em 30 de jul. de 2026 · NCT06325046

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
Marshfield Medical Center-EC Cancer Center, Eau Claire
e mais 10

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT05691465

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

University of Wisconsin, Madison

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 9 de jul. de 2026 · NCT07103018

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

University of Wisconsin Carbone Cancer Center, Madison

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 9 de jul. de 2026 · NCT05413421

Integrated Cancer Repository for Cancer Research

Bellin Memorial Hospital, Green Bay

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699

Using FAPI PET/MRI to Evaluate Prostate Cancer

University of Wisconsin, Madison

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT06675357

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

University of Wisconsin Carbone Cancer Center, Madison

RecrutandoEstudo observacional

Idades 21 e acima · Homens · Atualizado em 22 de mai. de 2026 · NCT03151629

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee

RecrutandoFase 2/3

Idades 18 e acima · Homens · Atualizado em 8 de abr. de 2026 · NCT04787744

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 20 de mar. de 2026 · NCT06705686

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

University of Wisconsin - Madison, Madison

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 11 de mar. de 2026 · NCT07090148

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.